The leading source for credible citizen reporting

Report Your News
Take the tour...

This event is older than two months and is no longer active. Some links older than two months could be broken.

Report Your News

Click here to post a new related report

Targeted drug strategy offers hope in skin cancer

Source: Reuters
Berlin : Germany | 2 months ago  
Views: 5
a $5 billion-a-year seller in colon, lung and breast cancer -- confounded expectations of doctors in Berlin, since a late-breaking abstract published earlier had reported a meaningful survival benefit. But a last-minute review of the clinical data changed the outcome and researchers said the Phase...
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon
News Stories
 
  • News Source: Uinta County News | 2 months ago
    Merck KGaA’s Erbitux Failed to Extend Lives in Study (Update2) Sept. 23 (Bloomberg) -- Merck KGaA and Eli Lilly & Co. ’s Erbitux drug failed to lengthen colon cancer patients’ lives or keep their disease from worsening, U.K. researchers said...
  • News Source: Reuters | 2 months ago
    a $5 billion-a-year seller in colon, lung and breast cancer -- confounded expectations of doctors in Berlin, since a late-breaking abstract published earlier had reported a meaningful survival benefit. But a last-minute review of the clinical data...
  • News Source: Reuters | 2 months ago
    Women with breast cancer lived significantly longer without their disease getting worse when treated with Bayer and Onyx Pharmaceuticals' cancer pill Nexavar, researchers said on Wednesday. Nexavar, a targeted anti-cancer drug sold as a liver and...
  • News Source: Uinta County News | 2 months ago
    Bayer, Onyx’s Nexavar Drug Helps Slow Breast Cancer Progression Sept. 21 (Bloomberg) -- Bayer AG’s and Onyx Pharmaceuticals Inc. ’s drug Nexavar helped stave off progression of breast tumors, the most common form of cancer in women, a study...
  • News Source: Uinta County News | 2 months ago
    Amgen Drug Falls Short in Colon Cancer Test, May Aid Merck KGaA Sept. 21 (Bloomberg) -- Amgen Inc. ’s cancer medicine Vectibix helped patients with colorectal tumors just a little more than chemotherapy in clinical trial results that may benefit...

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.